# Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis

> **NCT02397629** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 62 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** This study has no intervention

## Key facts

- **NCT ID:** NCT02397629
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02397629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02397629, "Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02397629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*